GeoVax Labs, Inc. (GOVX) Misses Q4 EPS by 63c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts GOVX Hot Sheet
Price: $0.17 +6.25%
EPS Growth %: -251.6%
Financial Fact:
Loss from operations: -464.54K
Today's EPS Names:
COHR, ATS, SICP, More
EPS Growth %: -251.6%
Financial Fact:
Loss from operations: -464.54K
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
GeoVax Labs, Inc. (NASDAQ: GOVX) reported Q4 EPS of ($0.83), $0.63 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $80 thousand versus the consensus estimate of $0 .
For earnings history and earnings-related data on GeoVax Labs, Inc. (GOVX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Phibro Animal Health (PAHC) Tops Q1 EPS by 2c; Offers Guidance
- Arcutis Biotherapeutics, Inc. (ARQT) Misses Q3 EPS by 12c; Offers Guidance
- SiTime Corp. (SITM) Tops Q3 EPS by 38c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
